TF and breast carcinoma: Later, Schaffner et al. demonstrated a cross-talk of tumor cell TF cytoplasmic domain and PAR2 signaling and showed that TF domain has additional roles via recognized β-arrestin recruitment site that are interdependent with PAR2 signaling in regulating host angiogenic responses in a TF and PAR2-positive clinical breast cancer [274].